Level Four Advisory Services LLC Buys 592 Shares of HealthEquity, Inc. $HQY

by · The Markets Daily

Level Four Advisory Services LLC boosted its position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 17.5% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,972 shares of the company’s stock after buying an additional 592 shares during the quarter. Level Four Advisory Services LLC’s holdings in HealthEquity were worth $416,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Invesco Ltd. lifted its holdings in shares of HealthEquity by 50.6% in the 1st quarter. Invesco Ltd. now owns 2,446,198 shares of the company’s stock worth $216,171,000 after acquiring an additional 821,425 shares during the last quarter. Westfield Capital Management Co. LP raised its position in HealthEquity by 124.6% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after purchasing an additional 701,819 shares during the period. Nuveen LLC bought a new stake in HealthEquity in the first quarter worth about $53,076,000. Price T Rowe Associates Inc. MD lifted its stake in HealthEquity by 995.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock worth $56,500,000 after purchasing an additional 580,988 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its position in shares of HealthEquity by 148.1% during the first quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company’s stock valued at $59,203,000 after buying an additional 399,897 shares during the period. Institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Down 2.6%

Shares of NASDAQ HQY opened at $102.41 on Tuesday. HealthEquity, Inc. has a twelve month low of $74.07 and a twelve month high of $116.65. The firm has a market cap of $8.82 billion, a PE ratio of 62.07, a price-to-earnings-growth ratio of 1.36 and a beta of 0.47. The business has a fifty day simple moving average of $96.24 and a two-hundred day simple moving average of $96.86. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY – Get Free Report) last announced its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. The firm had revenue of $325.80 million for the quarter, compared to analyst estimates of $320.68 million. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%. Analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on HQY. BMO Capital Markets initiated coverage on HealthEquity in a report on Thursday, November 13th. They issued a “market perform” rating and a $100.00 price target on the stock. Royal Bank Of Canada increased their target price on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 3rd. Barrington Research reiterated an “outperform” rating and set a $125.00 target price on shares of HealthEquity in a research report on Friday, August 29th. Jefferies Financial Group boosted their target price on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, September 3rd. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $119.00.

View Our Latest Report on HealthEquity

Insider Activity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Delano Ladd sold 6,000 shares of the business’s stock in a transaction dated Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the sale, the executive vice president owned 79,456 shares of the company’s stock, valued at approximately $7,477,604.16. This represents a 7.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 10,781 shares of company stock worth $1,016,707. 1.50% of the stock is owned by company insiders.

About HealthEquity

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).